More importantly, Iso treatment also upregulated Nrf2 downstream protective factors, such as HO-1, SOD1, and SOD2, which may explain the anti-inflammatory effect of Iso on CS-induced COPD. The gene discussed is SOD1; the disease is chronic obstructive pulmonary disease.